Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2017 Filed Jan 31, 2017 21:08 UTC |
LAND RAYMOND JDirector
|
GrantCommon Stock | 1,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-000588 · formfour.xml · nonDerivative · entry 1 LAND RAYMOND J · CIK 0001225613 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,159 F1 · security: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 27, 2018. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:08 UTC |
Hague RichardChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $50.13 | $0.00 |
DisclosureSEC source: 0001171843-17-000587 · formfour.xml · derivative · entry 1 Hague Richard · CIK 0001656557 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2027-01-27 F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning January 27, 2018. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:07 UTC |
Cheung SylviaChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $50.13 | $0.00 |
DisclosureSEC source: 0001171843-17-000586 · formfour.xml · derivative · entry 1 Cheung Sylvia · CIK 0001572857 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2027-01-27 F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning January 27, 2018. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:07 UTC |
Bower Joseph L.Director
|
GrantCommon Stock | 1,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-17-000585 · formfour.xml · nonDerivative · entry 1 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,536 F1 · security: These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on January 27, 2018. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:05 UTC |
Ahn Edward S.Chief Tech & Strategy Officer
|
GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $50.13 | $0.00 |
DisclosureSEC source: 0001171843-17-000583 · formfour.xml · derivative · entry 1 Ahn Edward S. · CIK 0001623597 · Chief Tech & Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2027-01-27 F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning January 27, 2018. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 21:06 UTC |
Alexander Dana M.Chief Operations Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,875 | $0.00 Strike: $50.13 | $0.00 |
DisclosureSEC source: 0001171843-17-000584 · formfour.xml · derivative · entry 1 Alexander Dana M. · CIK 0001670884 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,875 Underlying: Common Stock · 16,875 shares Expires 2027-01-27 F1 · derivative.exercise_date: The stock options vest in three equal annual installments beginning January 27, 2018. Read SEC document |
| December 22, 2016 Filed Jan 26, 2018 21:12 UTC |
WHEELER STEVE EDirector
|
OtherCommon Stock | 1,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001171843-18-000697 · form4wheeler.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,126 F1 · security: The total number of shares beneficially owned by the reporting person was incorrectly stated in Column 5 of the Form 4 filed by the reporting person on January 31, 2017. That total share number included these 1,955 shares, which were transferred on December 22, 2016 pursuant to a settlement agreement effective June 12, 2014. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 00:05 UTC |
Bower Joseph L.Director
|
SaleCommon Stock | 40 | $43.31 | $1,732.40 |
DisclosureSEC source: 0001171843-16-013102 · f4_bower110916.xml · nonDerivative · entry 4 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,542 F3 · security: Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 00:05 UTC |
Bower Joseph L.Director
|
SaleCommon Stock | 500 | $43.40 | $21,700.00 |
DisclosureSEC source: 0001171843-16-013102 · f4_bower110916.xml · nonDerivative · entry 3 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,582 F3 · security: Reflects an aggregate of 540 shares of common stock sold to satisfy tax obligations related to the exercise of the above listed SARs award by the Reporting Person on November 9, 2016. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 00:05 UTC |
Bower Joseph L.Director
|
Exercise / conversionStock Appreciation Right · Derivative | 1,540 | $0.00 Strike: $12.36 | $0.00 |
DisclosureSEC source: 0001171843-16-013102 · f4_bower110916.xml · derivative · entry 5 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,540 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. F1 · derivative.exercise_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. F1 · derivative.expiration_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 00:05 UTC |
Bower Joseph L.Director
|
Tax withholdingCommon Stock | 431 | $44.26 | $19,076.06 |
DisclosureSEC source: 0001171843-16-013102 · f4_bower110916.xml · nonDerivative · entry 2 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,082 F2 · security: Reflects 431 shares of common stock utilized to cover the exercise price of the above listed SARs award by the Reporting Person on November 7, 2016. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 00:05 UTC |
Bower Joseph L.Director
|
Exercise / conversionCommon Stock | 1,540 | $12.36 | $19,034.40 |
DisclosureSEC source: 0001171843-16-013102 · f4_bower110916.xml · nonDerivative · entry 1 BOWER JOSEPH I · CIK 0001227947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC |
WHEELER STEVE EDirector
|
Exercise / conversionStock Appreciation Right · Derivative | 1,090 | $0.00 Strike: $12.36 | $0.00 |
DisclosureSEC source: 0001171843-16-012958 · f4_wheeler110316.xml · derivative · entry 2 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. F1 · derivative.expiration_date: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:05 UTC |
WHEELER STEVE EDirector
|
Exercise / conversionCommon Stock | 1,090 | $12.36 | $13,472.40 |
DisclosureSEC source: 0001171843-16-012958 · f4_wheeler110316.xml · nonDerivative · entry 1 WHEELER STEVE E · CIK 0001250755 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Exercise of stock appreciation rights ("SARs") granted on December 14, 2006, which vested in full immediately on such date, and expiring on December 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.